Credit Suisse’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $873K | Buy |
65,742
+2,889
| +5% | +$38.4K | ﹤0.01% | 2339 |
|
|
2023
Q4 | $876K | Buy |
62,853
+13,196
| +27% | +$184K | ﹤0.01% | 2411 |
|
|
2023
Q3 | $658K | Sell |
49,657
-4,689
| -9% | -$62.2K | ﹤0.01% | 2527 |
|
|
2023
Q2 | $1.02M | Buy |
54,346
+15,800
| +41% | +$296K | ﹤0.01% | 2354 |
|
|
2023
Q1 | $556K | Buy |
38,546
+1,841
| +5% | +$26.5K | ﹤0.01% | 2676 |
|
|
2022
Q4 | $710K | Buy |
36,705
+8,061
| +28% | +$156K | ﹤0.01% | 2555 |
|
|
2022
Q3 | $984K | Buy |
28,644
+16,111
| +129% | +$553K | ﹤0.01% | 2331 |
|
|
2022
Q2 | $191K | Buy |
12,533
+412
| +3% | +$6.28K | ﹤0.01% | 3329 |
|
|
2022
Q1 | $276K | Buy |
12,121
+1,251
| +12% | +$28.5K | ﹤0.01% | 3246 |
|
|
2021
Q4 | $402K | Buy |
+10,870
| New | +$402K | ﹤0.01% | 3162 |
|